These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. Johnson MP, Conarty PF, Nichols DE. Eur J Pharmacol; 1991 Jul 23; 200(1):9-16. PubMed ID: 1685125 [Abstract] [Full Text] [Related]
3. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration. Johnson MP, Nichols DE. Pharmacol Biochem Behav; 1989 May 23; 33(1):105-8. PubMed ID: 2476831 [Abstract] [Full Text] [Related]
4. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI, Murray TK, Green AR. Br J Pharmacol; 1993 Mar 23; 108(3):583-9. PubMed ID: 7682129 [Abstract] [Full Text] [Related]
5. p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent. Huang X, Marona-Lewicka D, Nichols DE. Eur J Pharmacol; 1992 Dec 08; 229(1):31-8. PubMed ID: 1473561 [Abstract] [Full Text] [Related]
6. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. McKenna DJ, Guan XM, Shulgin AT. Pharmacol Biochem Behav; 1991 Mar 08; 38(3):505-12. PubMed ID: 1829838 [Abstract] [Full Text] [Related]
7. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine. Colado MI, O'Shea E, Granados R, Murray TK, Green AR. Br J Pharmacol; 1997 Jul 08; 121(5):889-900. PubMed ID: 9222545 [Abstract] [Full Text] [Related]
9. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. O'Loinsigh ED, Boland G, Kelly JP, O'Boyle KM. Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr 08; 25(3):621-38. PubMed ID: 11371001 [Abstract] [Full Text] [Related]
10. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue. Johnson MP, Huang XM, Nichols DE. Pharmacol Biochem Behav; 1991 Dec 08; 40(4):915-22. PubMed ID: 1726189 [Abstract] [Full Text] [Related]
11. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Fattaccini CM, Gozlan H, Hamon M. Neuropharmacology; 1991 Jan 08; 30(1):15-23. PubMed ID: 1710793 [Abstract] [Full Text] [Related]
12. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds. Colado MI, Green AR. Br J Pharmacol; 1994 Jan 08; 111(1):131-6. PubMed ID: 7516800 [Abstract] [Full Text] [Related]
13. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR. Toxicol Appl Pharmacol; 1988 Jul 08; 94(3):448-57. PubMed ID: 2456631 [Abstract] [Full Text] [Related]
14. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB. J Pharmacol Exp Ther; 1987 Sep 08; 242(3):911-6. PubMed ID: 2443644 [Abstract] [Full Text] [Related]
16. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Hiramatsu M, Cho AK. Neuropharmacology; 1990 Mar 08; 29(3):269-75. PubMed ID: 1691459 [Abstract] [Full Text] [Related]
19. Psychostimulant-like effects of p-fluoroamphetamine in the rat. Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE. Eur J Pharmacol; 1995 Dec 12; 287(2):105-13. PubMed ID: 8749023 [Abstract] [Full Text] [Related]